These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

453 related items for PubMed ID: 12037748

  • 21. Cisplatin, doxorubicin, and delayed surgery for childhood hepatoblastoma: a successful approach--results of the first prospective study of the International Society of Pediatric Oncology.
    Pritchard J, Brown J, Shafford E, Perilongo G, Brock P, Dicks-Mireaux C, Keeling J, Phillips A, Vos A, Plaschkes J.
    J Clin Oncol; 2000 Nov 15; 18(22):3819-28. PubMed ID: 11078495
    [Abstract] [Full Text] [Related]

  • 22. Surgical view of the treatment of patients with hepatoblastoma: results from the first prospective trial of the International Society of Pediatric Oncology Liver Tumor Study Group.
    Schnater JM, Aronson DC, Plaschkes J, Perilongo G, Brown J, Otte JB, Brugieres L, Czauderna P, MacKinlay G, Vos A.
    Cancer; 2002 Feb 15; 94(4):1111-20. PubMed ID: 11920482
    [Abstract] [Full Text] [Related]

  • 23. Surgical Resection for Hepatoblastoma-Updated Survival Outcomes.
    Sunil BJ, Palaniappan R, Venkitaraman B, Ranganathan R.
    J Gastrointest Cancer; 2018 Dec 15; 49(4):493-496. PubMed ID: 28963691
    [Abstract] [Full Text] [Related]

  • 24. Successful treatment of childhood high-risk hepatoblastoma with dose-intensive multiagent chemotherapy and surgery: final results of the SIOPEL-3HR study.
    Zsíros J, Maibach R, Shafford E, Brugieres L, Brock P, Czauderna P, Roebuck D, Childs M, Zimmermann A, Laithier V, Otte JB, de Camargo B, MacKinlay G, Scopinaro M, Aronson D, Plaschkes J, Perilongo G.
    J Clin Oncol; 2010 May 20; 28(15):2584-90. PubMed ID: 20406943
    [Abstract] [Full Text] [Related]

  • 25. Improved long-term survival with preoperative chemotherapy for hepatoblastoma.
    Ehrlich PF, Greenberg ML, Filler RM.
    J Pediatr Surg; 1997 Jul 20; 32(7):999-1002; discussion 1002-3. PubMed ID: 9247221
    [Abstract] [Full Text] [Related]

  • 26. Cisplatin versus cisplatin plus doxorubicin for standard-risk hepatoblastoma.
    Perilongo G, Maibach R, Shafford E, Brugieres L, Brock P, Morland B, de Camargo B, Zsiros J, Roebuck D, Zimmermann A, Aronson D, Childs M, Widing E, Laithier V, Plaschkes J, Pritchard J, Scopinaro M, MacKinlay G, Czauderna P.
    N Engl J Med; 2009 Oct 22; 361(17):1662-70. PubMed ID: 19846851
    [Abstract] [Full Text] [Related]

  • 27. Dose-dense cisplatin-based chemotherapy and surgery for children with high-risk hepatoblastoma (SIOPEL-4): a prospective, single-arm, feasibility study.
    Zsiros J, Brugieres L, Brock P, Roebuck D, Maibach R, Zimmermann A, Childs M, Pariente D, Laithier V, Otte JB, Branchereau S, Aronson D, Rangaswami A, Ronghe M, Casanova M, Sullivan M, Morland B, Czauderna P, Perilongo G, International Childhood Liver Tumours Strategy Group (SIOPEL).
    Lancet Oncol; 2013 Aug 22; 14(9):834-42. PubMed ID: 23831416
    [Abstract] [Full Text] [Related]

  • 28. Treatment of hepatoblastoma: less extensive hepatectomy after effective preoperative chemotherapy with cisplatin and adriamycin.
    Seo T, Ando H, Watanabe Y, Harada T, Ito F, Kaneko K, Horibe K, Sugito T, Ito T.
    Surgery; 1998 Apr 22; 123(4):407-14. PubMed ID: 9551066
    [Abstract] [Full Text] [Related]

  • 29. Hepatocellular carcinoma in children and adolescents: results from the Pediatric Oncology Group and the Children's Cancer Group intergroup study.
    Katzenstein HM, Krailo MD, Malogolowkin MH, Ortega JA, Liu-Mares W, Douglass EC, Feusner JH, Reynolds M, Quinn JJ, Newman K, Finegold MJ, Haas JE, Sensel MG, Castleberry RP, Bowman LC.
    J Clin Oncol; 2002 Jun 15; 20(12):2789-97. PubMed ID: 12065555
    [Abstract] [Full Text] [Related]

  • 30. Development of unfavorable hepatoblastoma in children of very low birth weight: results of a surgical and pathologic review.
    Ikeda H, Hachitanda Y, Tanimura M, Maruyama K, Koizumi T, Tsuchida Y.
    Cancer; 1998 May 01; 82(9):1789-96. PubMed ID: 9576303
    [Abstract] [Full Text] [Related]

  • 31. [Results of the HB-89 Study in treatment of malignant epithelial liver tumors in childhood and concept of a new HB-94 protocol].
    von Schweinitz D, Bürger D, Bode U, Weinel P, Erttmann R, Hecker H, Mildenberger H.
    Klin Padiatr; 1994 May 01; 206(4):282-8. PubMed ID: 7526028
    [Abstract] [Full Text] [Related]

  • 32. Survival after liver transplantation for hepatoblastoma: a 2-center experience.
    Browne M, Sher D, Grant D, Deluca E, Alonso E, Whitington PF, Superina RA.
    J Pediatr Surg; 2008 Nov 01; 43(11):1973-81. PubMed ID: 18970927
    [Abstract] [Full Text] [Related]

  • 33. A trend of improved survival of childhood hepatoblastoma treated with cisplatin and doxorubicin in Taiwanese children.
    Chiu SN, Ni YH, Lu MY, Lin DT, Lin KH, Lai HS, Chang MH.
    Pediatr Surg Int; 2003 Oct 01; 19(8):593-7. PubMed ID: 14556026
    [Abstract] [Full Text] [Related]

  • 34. Fibrolamellar hepatocellular carcinoma in children and adolescents.
    Katzenstein HM, Krailo MD, Malogolowkin MH, Ortega JA, Qu W, Douglass EC, Feusner JH, Reynolds M, Quinn JJ, Newman K, Finegold MJ, Haas JE, Sensel MG, Castleberry RP, Bowman LC.
    Cancer; 2003 Apr 15; 97(8):2006-12. PubMed ID: 12673731
    [Abstract] [Full Text] [Related]

  • 35. A study of therapy for pediatric hepatoblastoma: prevention and treatment of pulmonary metastasis.
    Uchiyama M, Iwafuchi M, Naito M, Yagi M, Iinuma Y, Kanada S, Tsukada K.
    Eur J Pediatr Surg; 1999 Jun 15; 9(3):142-5. PubMed ID: 10427488
    [Abstract] [Full Text] [Related]

  • 36. Liver transplantation and chemotherapy for hepatoblastoma and hepatocellular cancer in childhood and adolescence.
    Reyes JD, Carr B, Dvorchik I, Kocoshis S, Jaffe R, Gerber D, Mazariegos GV, Bueno J, Selby R.
    J Pediatr; 2000 Jun 15; 136(6):795-804. PubMed ID: 10839879
    [Abstract] [Full Text] [Related]

  • 37. Analysis of treatment efficiency of carboplatin and etoposide in combination with radical surgery in advanced and recurrent childhood hepatoblastoma: a report of the German Cooperative Pediatric Liver Tumor Study HB 89 and HB 94.
    Fuchs J, Bode U, von Schweinitz D, Weinel P, Erttmann R, Harms D, Mildenberger H.
    Klin Padiatr; 1999 Jun 15; 211(4):305-9. PubMed ID: 10472567
    [Abstract] [Full Text] [Related]

  • 38. Carboplatin-epirubicin regimen for the treatment of hepatoblastoma.
    Blouin P, Brugières L, Tabone MD, Leverger G, Rubie H, Branchereau S, De Kraker J.
    Pediatr Blood Cancer; 2004 Feb 15; 42(2):149-54. PubMed ID: 14752879
    [Abstract] [Full Text] [Related]

  • 39. Pretreatment prognostic factors and treatment results in children with hepatoblastoma: a report from the German Cooperative Pediatric Liver Tumor Study HB 94.
    Fuchs J, Rydzynski J, Von Schweinitz D, Bode U, Hecker H, Weinel P, Bürger D, Harms D, Erttmann R, Oldhafer K, Mildenberger H, Study Committee of the Cooperative Pediatric Liver Tumor Study Hb 94 for the German Society for Pediatric Oncology and Hematology.
    Cancer; 2002 Jul 01; 95(1):172-82. PubMed ID: 12115331
    [Abstract] [Full Text] [Related]

  • 40. Changing treatment and outcome of children with hepatoblastoma: analysis of a single center experience over the last 20 years.
    Ismail H, Broniszczak D, Kaliciński P, Dembowska-Bagińska B, Perek D, Teisseyre J, Kluge P, Kościesza A, Lembas A, Markiewicz M.
    J Pediatr Surg; 2012 Jul 01; 47(7):1331-9. PubMed ID: 22813792
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 23.